College of Medicine & Dentistry
Semagn Abate
- Doctor of Philosophy (Health)
- semagn.abate@my.jcu.edu.au
Joseph Kamara
- Senior Lecturer Disaster Health and Humanitarian Assistance
- joseph.kamara@jcu.edu.au
Eric Kalo
- Lecturer Medical Education
- eric.kalo@jcu.edu.au
Erin Waters
- JCU Associate Professor
- erin.waters@jcu.edu.au
Kannan Maharajan
- Associate Professor, Pharmacy
- kannan.maharajan@jcu.edu.au
Fahmida Begum Mina
- Doctor of Philosophy (Medical, Molecular and Veterinary Sciences)
- fahmidabegum.mina@my.jcu.edu.au
Lynsey Brown
- Adjunct Senior Lecturer
- lynsey.brown@jcu.edu.au
Ali Isin
- Adjunct Senior Research Fellow
- ali.isin@jcu.edu.au
Muideen Olaiya
- Senior Research Fellow
- muideen.olaiya@jcu.edu.au
Mila Grinblat
- Postdoctoral Research Fellow
- mila.grinblat@jcu.edu.au
Supervised Home Exercise for Peripheral Artery Disease (Old ID 27514)
Joseph Moxon
01 Jun 2023 - 31 May 2027
1 million Australians have leg artery blockage (peripheral artery disease; PAD) and are at very high risk of major adverse cardiovascular events. Up to one-third of patients having an acute cardiac event or stroke have PAD, which limits their recovery. Randomised controlled trials (RCT) have established supervised exercise therapy substantially improves the functional impairment caused by PAD and reduces the risk factors of acute cardiovascular events. International guidelines recommend supervised exercise therapy sessions are performed at tertiary facilities three times weekly for three months. These programs have poor uptake and are not suited to equitable provision across Australia particularly for regional and remote communities who have the greatest burden from PAD. Our workshops with patients indicated the commonest challenges to taking part in supervised exercise was travelling. In partnership with patients, health professionals and other stakeholders we have co-designed the Supervised Home-based exercise progrAm for Peripheral artery diseasE (SHAPE). This 12-week supervised exercise program is delivered directly to and completely undertaken within the participant's home using telehealth supervision and monitoring from a wrist worn accelerometer
Developing research capacity in Weipa, Cape York (Old ID 27442)
Sally West
25 Jan 2022 - 25 Jan 2023
This application is to support a program of health services and biomedical research in Weipa, Cape York. This encompasses 5 research projects that are active (3) or in development stages (2). Active projects: Implementation of Nasal High Flow in the Remote Context (PARIS-REMOTE), Evaluation of Cape York Kidney Care model of care, Evaluation of a student-assisted community rehabilitation service. Developing projects include: Implementation of chronic obstructive pulmonary disease and cardiac rehabilitation services across Cape York, and Identifying pathogenesis of middle ear disease, goal directed therapy and review of antibiotic resistance through in Cape York.
Knowledge Brokering from the Bottom Up: Co-designing Climate Information Products with the Kwaio people of Malaita Province, Solomon Islands (Old ID 28981)
Michelle Redman-MacLaren
27 Apr 2023 - 30 Apr 2024
Baru Conservation Alliance (BCA) and JCU successfully implemented the APCP funded “Traditional Knowledge about Climate and Food Security in Kwaio, Malaita, Solomon Islands” in 2021/22. This current “Knowledge Brokering from the Bottom Up: Co-designing Climate Information Products with the Kwaio people” project strengthens capacity built in 2021/22 to inform climate information products based on Kwaio traditional knowledge. The project will create communication products that utlise both western scientific and traditional Kwaio knowledge about the weather, how the weather is changing and what this means for people living on Malaita, Solomon Islands.
National Research Project on Remote Radiology Assessment Service Delivery (Old ID 23150)
Rebecca Evans
01 May 2017 - 30 Nov 2019
This project will investigate outcomes of the BreastScreen Australia remote radiology assessment trial at sites through9out Australia. Engaging a remote radiologist may assist with overcoming many challenges associated with providing health services in a regional, rural or remote location. This project seeks to ensure that the alternative model of service delivery is appropriate for consumers, evidence-based and safe. Specifically, this project will assess how the new remote radiology model affects: - Patient safety - Patient acceptability - Staff acceptability of new model of service provision - The safe, efficient organisation of BreastScreen services
National Research Project on Remote Radiology Assessment Service Delivery (Old ID 23150)
Karen Johnston
01 May 2017 - 30 Nov 2019
This project will investigate outcomes of the BreastScreen Australia remote radiology assessment trial at sites through9out Australia. Engaging a remote radiologist may assist with overcoming many challenges associated with providing health services in a regional, rural or remote location. This project seeks to ensure that the alternative model of service delivery is appropriate for consumers, evidence-based and safe. Specifically, this project will assess how the new remote radiology model affects: - Patient safety - Patient acceptability - Staff acceptability of new model of service provision - The safe, efficient organisation of BreastScreen services
Point-of-injury intranasal ALM drug therapy to reduce secondary injury and improve outcomes after TBI in civilian and military resource-limited environments (Old ID 27829)
Hayley Letson
01 Sep 2023 - 31 Aug 2026
Currently there is no effective drug therapy to treat traumatic brain injury (TBI) in combat and other military and civilian settings immediately after the injury has occurred that can protect the brain and the whole body by reducing secondary injury progression and TBI-associated complications. ALM therapy is a neuroprotective fluid therapy that significantly improves survival, rescues cardiac function, reduces local bleeding, and blunts secondary injury processes including inflammation after trauma. This project will evaluate the efficacy and protective benefits of ALM therapy administered intravenously (injectable) and intranasally (via spray) in a rat model of TBI.
Point-of-injury intranasal ALM drug therapy to reduce secondary injury and improve outcomes after TBI in civilian and military resource-limited environments (Old ID 27829)
Jodie Morris
01 Sep 2023 - 31 Aug 2026
Currently there is no effective drug therapy to treat traumatic brain injury (TBI) in combat and other military and civilian settings immediately after the injury has occurred that can protect the brain and the whole body by reducing secondary injury progression and TBI-associated complications. ALM therapy is a neuroprotective fluid therapy that significantly improves survival, rescues cardiac function, reduces local bleeding, and blunts secondary injury processes including inflammation after trauma. This project will evaluate the efficacy and protective benefits of ALM therapy administered intravenously (injectable) and intranasally (via spray) in a rat model of TBI.
CSIRO Confidentiality Agreement - Fytobio
Craig McFarlane
18 Mar 2024 - 18 Mar 2026
Will discuss research of group with CSIRO Protein Production Group with respect to Fytobio.
International travel and medical events- an Australian travel insurance perspective in the Covid-19 era.
Lars Henning
01 Apr 2024 - 31 Dec 2027
This PhD project will measure the impact of international travel on the medical wellbeing of Australians. No such data currently exists. By investigating the relationship between traveller features and communicable and non-communicable diseases, an indication of the true medical risks associated with such travel will be established. The measurements will reflect long-term impacts of the COVID-19 pandemic on medical literacy, travel preferences, and public attitudes. The results will inform future product design for insurers and assist travel medical providers to advise clients on their risk for medical incidents during travel. The findings will assist in setting the healthcare expectations for contemporary Australian international travellers.
International travel and medical events- an Australian travel insurance perspective in the Covid-19 era.
Maru Castellanos Reynosa
01 Apr 2024 - 31 Dec 2027
This PhD project will measure the impact of international travel on the medical wellbeing of Australians. No such data currently exists. By investigating the relationship between traveller features and communicable and non-communicable diseases, an indication of the true medical risks associated with such travel will be established. The measurements will reflect long-term impacts of the COVID-19 pandemic on medical literacy, travel preferences, and public attitudes. The results will inform future product design for insurers and assist travel medical providers to advise clients on their risk for medical incidents during travel. The findings will assist in setting the healthcare expectations for contemporary Australian international travellers.
Regenerating lizard tails: A new model for investigating lymphangiogenesis
- 2003
- Researchers:Suzy Munns
Association of osteoprotegerin with human abdominal aortic aneurysm progression
- 2005
- American Heart Association
- Researchers:Jonathan Golledge
A simple plan: cnidarians and the origins of developmental mechanisms
- 2004
- Nature Publishing
- Researchers:David Miller
Title:
KAI 2022 Scholarship to attend KAI International Meeting, 2022, Songdo Convensia, Incheon, Korea
Start Date:
01 Jan 2022
Start Date:
01 Jan 2025
Start Date:
01 Jan 2021
Start Date:
01 Jan 2025
End Date:
01 Jan 2025
Start Date:
01 Jan 2015
End Date:
01 Jan 2015
Start Date:
01 Jan 2013
End Date:
01 Jan 2013
Start Date:
01 Jan 2013
End Date:
01 Jan 2013
Start Date:
01 Jan 2013
End Date:
01 Jan 2013
Title:
WONCA, Prague, 2013.
Start Date:
01 Jan 2013
End Date:
01 Jan 2013
Title:
AMEE, Lyon, 2012
Start Date:
01 Jan 2012
End Date:
01 Jan 2012